JPJames W. Pritchett

James W. Pritchett

*This is an algorithmically generated author record based on publicly available information.

James W. Pritchett has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hip resurfacing arthroplasty with cemented highly cross-linked all polyethylene acetabular components

    by James W. Pritchett

    Background: Hip resurfacing arthroplasty (HRA) is needed for certain patients, such as those with in situ metal work and abnormal anatomy, and/or other needs that are not well-served by total hip replacement (THR). Over the last 20 years, almost all HRAs have been performed using Metal-on-Metal (MoM) bearings, but metal wear debris generated over time has now ended their continued use. Cemented highly cross-linked polyethylene (XLPE) acetabular bearings have shown excellent survivorship for use in THR and the aim of this study is to determine if this also applied to HRA. Methods: This prospective cohort study evaluated extending the use of cemented XLPE acetabular bearings to HRA. There were 122 HRA patients who received a cemented XLPE acetabular component. They were followed for a mean 15 years (range, 10–20 years). There were 65 women (53%) and 57 men (47%). The mean age at surgery was 49.2 years (range, 21–68 years) the mean body mass index (BMI) was 26 kg/m2. Clinical outcomes and survivorship were determined. Analyses of implants retrieved during revision or postmortem were performed to evaluate consequences of wear debris. Results: The 10-year survival rate for 122 hips was 93.5% [95% confidence interval (CI): 91.7–98.1%] for all-cause revision. Six acetabular bearings failed, requiring revision for: loosening [2], polyethylene wear [2], and dislocation [2]. Four additional well-functioning XLPE bearings were retrieved postmortem. Two well-functioning cemented acetabular bearings were also retrieved; one was an explant for an infection after 9 years and the other was retrieved during revision to THR because of femoral head avascular necrosis at 6 years. Analysis of the 12 retrievals found signs of limited anterior/superior wear in all bearings along with minimal wear in the dome of 10 bearings. Only two retrieved bearings had more than 50% of the anterior/superior area worn and these were after 15 and 20 years of use. Two of the retrieved implants had no signs of wear. Conclusions: Cemented all XLPE acetabular bearings produced successful clinical outcomes initially in all patients. Six (4.9%) patients required revision for acetabular failure. Anterior/superior wear was found in the retrievals, but dome wear was limited. Cementing an XLPE acetabular component is a reasonable approach in HRA, but since it does not allow adjunct screw fixation that a metal-backed two-piece component can offer, it is not a solution for every HRA.

  • Open Access

    Polyethylene hip resurfacing in patients with lower leg amputations

    by James W. Pritchett

    Patients with lower leg amputations tend to develop hip osteoarthritis more frequently and at a younger age than the general population. Some amputee patients choose hip resurfacing arthroplasty (HRA) because of its bone conservation compared to total hip arthroplasty. Because of their altered gait mechanics, HRA might provide these patients with stability and functional benefits compared to total hip arthroplasty. The hypothesis is that HRA is a useful and successful alternative to total hip replacement for lower extremity amputees requiring hip implant surgery. The aim of this study was to evaluate if HRA is a successful alternative to total hip replacement in this patient population with altered gait mechanics. This observational study reviewed the records of 39 amputee patients (45 hips) who underwent HRA using a polyethylene acetabular component. Trauma, tumor, vascular disease, infection, and congenital conditions were indications for amputation. Above knee and below knee amputations were included. Patients were evaluated using the Hip Disability and Osteoarthritis Outcome Score (HOOS), Harris Hip Score (HHS), Minimal Clinically Important Difference (MCID), and Patient Acceptable Symptomatic State (PASS). Follow-up included implant survivorship, complications, and radiographic evaluation for implant osseointegration, wear, position, and leg length. Mean follow-up was 13 years (range, 3–40 years). Mean HOOS was 90, mean HHS was 92; 92% of patients achieved MCID (which required an improvement of 38 points in HOOS and 37 points in HHS), and 85% achieved PASS. There was one revision for femoral head avascular necrosis, one conventional polyethylene exchange for wear, and six temporary complications. Thirty-three (85%) patients had a leg length difference of >1 cm (range, 1–4.7 cm); the prosthetic limb was shorter in 25 (75%) and longer in 8 (25%). No patient was concerned with leg length difference and there were no differences in hip scores and implant survivorship based on limb length. HRA is a demanding procedure that can be successful for patients with lower limb amputations. An unexpected finding was that leg length differences are common in these patients. Unequal leg lengths did not adversely affect implant survivorship or patient-reported outcomes.

  • Open Access

    Cementless Metal-Free Ceramic-Coated Shoulder Resurfacing

    by James W. Pritchett

    Shoulder resurfacing is a versatile, bone-conserving procedure to treat arthritis, avascular necrosis, and rotator cuff arthropathy. Shoulder resurfacing is of interest to young patients who are concerned about implant survivorship and those in need of a high level of physical activity. Using a ceramic surface reduces wear and metal sensitivity to clinically unimportant levels. Between 1989 and 2018, 586 patients received cementless, ceramic-coated shoulder resurfacing implants for arthritis, avascular necrosis, or rotator cuff arthropathy. They were followed for a mean of 11 years and were assessed using the Simple Shoulder Test (SST) and Patient Acceptable Symptom State (PASS). CT scans were used in 51 hemiarthroplasty patients to assess the glenoid cartilage wear. Seventy-five patients had a stemmed or stemless implant in the contralateral extremity. A total of 94% of patients had excellent or good clinical results and 92% achieved PASS. 6% of patients required a revision. A total of 86% of patients preferred their shoulder resurfacing prosthesis over a stemmed or stemless shoulder replacement. The glenoid cartilage wear at a mean of 10 years was 0.6 mm by a CT scan. There were no instances of implant sensitivity. Only one implant was removed due to a deep infection. Shoulder resurfacing is an exacting procedure. It is clinically successful, with excellent long-term survivorship in young and active patients. The ceramic surface has no metal sensitivity, very low wear, and, therefore, it is successful as a hemiarthroplasty.


  • Open Access

    Salvaging failed metal-on-metal hip resurfacing with a polyethylene acetabular revision

    by James W. Pritchett

    Original Article Salvaging failed metal-on-metal hip resurfacing with a polyethylene acetabular revision James W. Pritchett

  • Unexpected operative death from hemorrhage: a review of six cases and recommendations

    by Pritchett, James W.

    All busy surgeons will eventually face a severe intraoperative hemorrhage and about one-third will have an intraoperative death. Situational awareness is the key to good operating room leadership and clinical performance. Technical, emotional, and professional skills are equally necessary. When hemorrhage occurs, some surgeons are affected by a “startle” response and freeze. An immediate surgical plan to stop the hemorrhage by pressure or direct vascular control is required. A stable patient presents other options such as waiting for additional surgical or interventional help; an unstable patient does not. The operating room team and family look to the surgeon as the threat-and-error manager. The surgeon must fill this role with a skilled, open, and compassionate approach rather than a hesitant, protective, or defensive approach. The urgent needs of the patient can require a surgeon to perform an unfamiliar or unpracticed exposure when there is no safe alternative. The emotional and professional cost of a fatal intraoperative hemorrhage is significant. With preparation, a better path for the surgeon, operating room staff and patient is possible. This review presents six actual scenarios of managing hemorrhage in orthopaedic surgery.

  • Open Access

    Wear and performance of a tripolar total hip replacement

    by James W. Pritchett

    Wear and performance of a tripolar total hip replacement James W. Pritchett


  • The debit side of stem-cell joint injections: a prospective cohort study

    by Pritchett, James W.

    Background: There is little long-term information and no prior report that used independently collected data describing the effectiveness and complications of intraarticular injections of stem cells. Methods: This study reviewed the records of 2964 patients who received stem-cell injections in the hip, knee, or shoulder and 2971 patients who had injections of steroids or viscosupplementation (comparison group). Results: Pain improved initially in 2104 (71%) of patients who received stem cells. At a mean follow-up of 5.6 yr, 563 (15%) patients continued to report less pain, and the mean time of pain reduction was 17 mo (range, 1 to 84 mo). The mean cost of stem-cell care was $6000 (range, $1200 to $13,000). There were 115 (8%) complications using autologous stem cells, 113 (8%) with donor cells, and 13 (9%) when both were used. Stem-cell complications included six tumors, 14 infections, 48 syncopal, arrhythmia, seizure, or vasovagal reactions, 42 chronic culture-negative effusions, 18 injection site rashes, 44 instances of systemic viral like syndrome or herpes zoster-like reactions, 31 new allergies, and 39 instances of acute and severe worsening of pain and function. There were 82 hospitalizations. For the comparison group, there were 61 (2%) complications and eight hospitalizations. Conclusions: The frequency (8%) and severity of complications with stem cell-injections is higher than for steroid or viscosupplementation injections (2%). Stem-cell joint injections are a costly and speculative treatment and should only be used with a deep understanding of the risk. Practitioners providing stem cell joint injections must include long-term follow-up as part of their care. Additional validated scientific studies are needed. Level of Evidence: Level II.


  • Open Access

    Polyethylene for hip resurfacing—worth a second look

    by James W. Pritchett, James W.

    Background: In the 1970s and 1980s, hip resurfacing was largely unsuccessful, due to impingement, wear, and component loosening. Today, the availability of better technique and highly cross-linked polyethylene avoids the early causes of failure and provides a successful solution to younger, active patients with advanced osteoarthritis. Methods: The author reviewed the results of 2,154 hip resurfacing arthroplasties he performed over a 21-year period. The procedures used a cementless titanium metal-backed acetabular implant and highly cross-linked polyethylene liner. Results: At a mean follow-up period of 9.5 years (range, 5–21 years), the Kaplan-Meier survivorship was 97.5%, the mean Harris Hip Score was 97, and the UCLA activity score was 8. There were 32 deaths unrelated to the procedure and 35 patients were lost to follow-up. Complications leading to revision included femoral loosening (n=9), infection (n=3), femoral neck fracture (n=12), and these were revised successfully to total hip replacement. Another five patients underwent revision resurfacing for acetabular loosening. There was no evidence of wear through of the polyethylene and examination of retrieved polyethylene components showed a low wear rate from 0.003 to 0.07 mm per year. Conclusions: Hip resurfacing today has proven to be a successful procedure with results as good as or better survivorship than total hip replacement and better function. It is a reliable procedure that meets the physical demands of younger, active patients.